1. Home
  2. CACC vs AMRX Comparison

CACC vs AMRX Comparison

Compare CACC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credit Acceptance Corporation

CACC

Credit Acceptance Corporation

SELL

Current Price

$542.47

Market Cap

5.5B

Sector

Finance

ML Signal

SELL

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

SELL

Current Price

$19.25

Market Cap

6.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CACC
AMRX
Founded
1972
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.4B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
CACC
AMRX
Price
$542.47
$19.25
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
★ $596.67
$22.71
AVG Volume (30 Days)
102.3K
★ 2.9M
Earning Date
10-29-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
83.00
★ 157.89
EPS
★ 25.04
0.37
Revenue
★ $2,317,200,000.00
N/A
Revenue This Year
$91.15
$4.53
Revenue Next Year
$6.09
$9.13
P/E Ratio
★ $21.98
$52.01
Revenue Growth
★ 7.16
N/A
52 Week Low
$401.90
$9.92
52 Week High
$668.86
$21.18

Technical Indicators

Market Signals
Indicator
CACC
AMRX
Relative Strength Index (RSI) 43.24 47.30
Support Level $529.10 $16.59
Resistance Level $543.00 $19.26
Average True Range (ATR) 15.87 0.62
MACD 2.21 -0.19
Stochastic Oscillator 64.17 11.78

Price Performance

Historical Comparison
CACC
AMRX

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: